Itano M, Tsuchiya S, Minegishi N, Fujie H, Minegishi M, Morita S, Yambe T, Ohashi Y, Masuda T, Koike T
Department of Pediatric Oncology, Tohoku University, Sendai, Japan.
Exp Hematol. 1995 Nov;23(12):1301-9.
A novel fibroblast-dependent human immature megakaryoblastic leukemia cell line (M-MOK) was established from the bone marrow of a girl with acute megakaryoblastic leukemia, and its growth was determined to be completely dependent on the presence of human embryonic lung-derived fibroblasts, HEL-O. Adhesive interaction between M-MOK and HEL-O was crucial for viability; once HEL-O was removed from the culture, mortality was total within a few days. On HEL-O cells, M-MOK could be passaged for more than 2 years. With regard to surface marker profile, the established cells were positive for CD11a, CD13, CD18, CD33, CD34, CD41b, CD42b, CD54, and c-kit antigens, but negative for HLA class II antigen and glycophorin. Histochemically, the cells were negative for myeloperoxidase, nonspecific esterase, and naphthol ASD chloroacetate esterase staining. Electron-microscope examination revealed the cells to be negative for platelet peroxidase (PPO). After induction of differentiation by a phorbol ester, however, the cells were demonstrated to be positive for PPO with a morphological change to megakaryocytes. From these results, M-MOK was considered to represent an immature cell line of megakaryocyte lineage. Studies of the mechanisms sustaining the HEL-O-dependent continuous in vitro growth of M-MOK cells revealed the following results: (1) M-MOK could grow even when separated from HEL-O by a nucleopore membrane; (2) conditioned medium (CM) from HEL-O supported the growth of M-MOK for more than 1 month without feeder cells; (3) the growth of M-MOK on HEL-O or CM supplement was nearly entirely inhibited by anti-GM-CSF (1 microgram/mL); (4) GM-CSF mRNA was detected in HEL-O cells; and (5) HEL-O was found to secrete GM-CSF into the culture medium. Taken together, the growth of M-MOK might therefore be driven by a soluble factor, that is, GM-CSF secreted from HEL-O cells. The presence of HEL-O, however, inhibited anti-GM-CSF-induced M-MOK death. Co-culture of M-MOK and HEL-O cells thus offers a useful experimental model for analysis of interactions between hematopoietic stem cells and stromal cells.
从一名急性巨核细胞白血病女孩的骨髓中建立了一种新型的成纤维细胞依赖性人未成熟巨核母细胞白血病细胞系(M-MOK),其生长被确定完全依赖于源自人胚胎肺的成纤维细胞HEL-O的存在。M-MOK与HEL-O之间的黏附相互作用对细胞活力至关重要;一旦从培养物中去除HEL-O,几天内细胞就会全部死亡。在HEL-O细胞上,M-MOK可以传代2年以上。关于表面标志物谱,所建立的细胞对CD11a、CD13、CD18、CD33、CD34、CD41b、CD42b、CD54和c-kit抗原呈阳性,但对HLA II类抗原和血型糖蛋白呈阴性。组织化学分析显示,这些细胞髓过氧化物酶、非特异性酯酶和萘酚ASD氯乙酸酯酶染色均为阴性。电子显微镜检查显示这些细胞血小板过氧化物酶(PPO)呈阴性。然而,经佛波酯诱导分化后,细胞PPO呈阳性,且形态学上转变为巨核细胞。根据这些结果,M-MOK被认为代表巨核细胞系的未成熟细胞系。对维持M-MOK细胞依赖HEL-O在体外持续生长的机制研究得出以下结果:(1)即使通过核孔膜与HEL-O分离,M-MOK仍能生长;(2)来自HEL-O的条件培养基(CM)在无饲养细胞的情况下支持M-MOK生长超过1个月;(3)抗GM-CSF(1微克/毫升)几乎完全抑制M-MOK在HEL-O或CM补充物上的生长;(4)在HEL-O细胞中检测到GM-CSF mRNA;(5)发现HEL-O将GM-CSF分泌到培养基中。综上所述,M-MOK的生长可能由一种可溶性因子驱动,即HEL-O细胞分泌的GM-CSF。然而,HEL-O的存在可抑制抗GM-CSF诱导的M-MOK死亡。因此,M-MOK与HEL-O细胞的共培养为分析造血干细胞与基质细胞之间的相互作用提供了一个有用的实验模型。